Research Article| Volume 233, ISSUE 1-2, P93-97, June 15, 2005

Vitamin B12, demyelination, remyelination and repair in multiple sclerosis


      Multiple Sclerosis (MS) and vitamin B12 deficiency share common inflammatory and neurodegenerative pathophysiological characteristics. Due to similarities in the clinical presentations and MRI findings, the differential diagnosis between vitamin B12 deficiency and MS may be difficult. Additionally, low or decreased levels of vitamin B12 have been demonstrated in MS patients. Moreover, recent studies suggest that vitamin B12, in addition to its known role as a co-factor in myelin formation, has important immunomodulatory and neurotrophic effects. These observations raise the questions of possible causal relationship between the two disorders, and suggest further studies of the need to close monitoring of vitamin B12 levels as well as the potential requirement for supplementation of vitamin B12 alone or in combination with the immunotherapies for MS patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Babior B.M.
        • Bunn H.F.
        Megaloblastic anemias.
        in: Braunwald E. Fauci A.S. Kasper D.L. Hauser S.L. Longo D.L. Jameson J.L. Harrison's principles of internal medicine. 15th ed. McGraw-Hill, New-York2001: 674-680
        • Babior B.M.
        The megaloblastic anemias.
        in: Butler E. Williams hematology. 6th ed. McGraw-Hill, New York2000
        • Victor M.
        • Ropper A.H.
        Diseases of the nervous system due to nutritional deficiency.
        in: Adams and Victor's principles of neurology. 7th ed. McGraw-Hill, New York2001: 1218-1222
        • Lee B.J.
        • Lin P.T.
        • Liaw Y.P.
        • Chang S.J.
        • Cheng C.H.
        • Huang Y.C.
        Homocysteine and risk of coronary artery disease: folate is the important determinant of plasma homocysteine concentration.
        Nutrition. 2003; 19: 577-583
        • Oh R.
        • Brown D.L.
        Vitamin B12 deficiency.
        Am Fam Physician. 2003; 67: 979-986
        • Lindenbaum J.
        • Savage D.
        • Stabler S.
        Diagnosis of cobalamin deficiency: relative sensitivity of serum cobalamin, methyl malonic acid and total homocysteine concentrations.
        Am J Hematol. 1990; 34: 99-107
        • Misra U.K.
        • Kalita J.
        • Das A.
        Vitamin B12 deficiency neurological syndromes: a clinical MRI and electrodiagnostic study.
        Electromyogr Clin Neurophysiol. 2003; 43: 57-64
        • Scherer K.
        Neurologic manifestations of vitamin B12 deficiency.
        NEJM. 2003; 348: 2208
        • Katsaros V.K.
        • Glocker F.X.
        • Hemmer B.
        MRI of spinal cord and brain lesions in subacute combined degeneration.
        Neuroradiology. 1999; 41: 387
        • Ghezzi A.
        • Zaffaroni M.
        Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis.
        Neurol Sci. 2001 (Nov); 22: S117-S122
        • Reynolds E.H.
        • Bottiglieri T.
        • Laundy M.
        • Crelline F.
        • Kirker S.G.
        Vitamin B12 metabolism in multiple sclerosis.
        Arch Neurol. 1992; 49: 649-652
        • Najim Al Din A.S.
        • Khojali M.
        • Habbosh H.
        • Farah S.
        • Idris A.R.
        • AI-Muhtasib F.
        Macrocytosis in multiple sclerosis: a study in 82 de novo Arab patients.
        J Neurol Neurosurg Psychiatry. 1991; 54: 415-416
        • Crellin R.F.
        • Bottiglieri T.
        • Reynolds E.H.
        Multiple sclerosis and macrocytosis.
        Acta Neurol Scand. 1990; 81: 388-391
        • Nijst T.Q.
        • Hommes O.R.
        • Weavers R.A.
        • Schoonder-Waldt H.C.
        • De Haan A.F.J.
        Vitamin B12 and folate levels of serum and cerebrospinal fluid in multiple sclerosis and other neurological disorders.
        J Neuro Neurosurg Psychiatry. 1990; 53: 951-954
        • Goodkin D.E.
        • Jacobsen D.W.
        • Galvez N.
        • Daughtry M.
        • Secic H.
        • Green R.
        Serum cobalamin deficiency is uncommon in multiple sclerosis.
        Arch Neurol. 1994; 54: 1110-1114
        • Vrethem M.
        • Mattsson E.
        • Hebelka H.
        • Leerbeck K.
        • Osterberg A.
        • Landtblom A.M.
        • et al.
        Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid.
        Mult Scler. 2003; 9: 239-245
        • Shevell M.I.
        • Rosenblatt D.S.
        The neurology of cobalamin.
        Neurol Sci. 1990; 19: 472
        • Allen R.H.
        Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency.
        FASEB J. 1993; 7: 1344
        • Peracchi M.
        • Bamonti Catena F.
        • Pomati M.
        • De Franceschi M.
        • Scalabrino G.
        Human cobalamin deficiency: alterations in serum tumour necrosis factor-alpha and epidermal growth factor.
        Eur J Haematol. 2001; 67: 123-127
        • Calder P.C.
        • Kew S.
        The immune system: a target for functional foods?.
        Br J Nutr. 2002; 88: S165-S177
        • Miller J.W.
        Vitamin B12 deficiency, tumor necrosis factor-alpha, and epidermal growth factor: a novel function for vitamin B12?.
        Nutr Rev. 2002; 60: 142-144
        • Schroecksnadel K.
        • Frick B.
        • Wirleitner B.
        • Winkler C.
        • Schennach H.
        • Fuchs D.
        Moderate hyperhomocysteinemia and immune activation.
        Curr Pharm Biotechnol. 2004; 5: 107-118
        • Frequin S.
        • Wavers R.A.
        • Braam M.
        • Barkhof F.
        • Hommes G.R.
        Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after intravenous methylprednisolone.
        J Neurol. 1993; 240: 305-308
        • Smith D.R.
        • Balashov K.E.
        • Hafler D.A.
        • Khoury S.J.
        • Weiner H.I.
        Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
        Ann Neurol. 1997; 42: 313-318
        • Miller A.
        • Shapiro S.
        • Gershtein R.
        • Kinarty A.
        • Rawashdeh H.
        • Honigman S.
        • et al.
        Treatment of multiple sclerosis with copolymer-1 (copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation.
        J Neuroimmunol. 1998; 92: 113-121
        • Kozovska M.E.
        • Hong J.
        • Zang Y.C.Q.
        • Li S.
        • Rivera V.M.
        • Killian J.M.
        • et al.
        Interferon beta induces T-helper 2 immune deviation in MS.
        Neurology. 1999; 53: 1687-1692
        • Borgia G.
        • Reynaud L.
        • Gentile I.
        • Borrelli F.
        • Cerini R.
        • Ciampi R.
        • et al.
        Pernicious anemia during IFN-alpha treatment for chronic hepatitis C.
        J Interferon Cytokine Res. 2003; 23: 11-12
        • Nousari H.C.
        • Asadi A.K.
        • Tausk F.A.
        Subacute cutaneous lupus erythomatosus associated with interferon beta 1a.
        Lancet. 1998; 352: 1825-1826
        • Durelli L.
        • Ferrero B.
        • Oggero O.
        • Verdun E.
        • Bongioanni M.K.
        • Gentile E.
        • et al.
        Autoimmune events during interferon beta 1b therapy for multiple sclerosis.
        J Neurol Sci. 1999; 162: 74-83
        • Kreiss Y.
        • Cohen O.
        • Pras E.
        • Achiron A.
        Subacute thyroiditis in a patient with multiple sclerosis treated with interferon beta 1a.
        Neurology. 1999; 53: 1606
        • Schwid S.R.
        • Goodman A.D.
        • Mattson D.H.
        Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta 1b.
        Arch Neurol. 1997; 54: 1169-1170
        • Rotondi M.
        • Mazziotti G.
        • Biondi B.
        • Mangallena G.
        • Del Buono A.D.
        • Montella P.
        • et al.
        Long term treatment with interferon beta therapy for multiple sclerosis and occurrence of graves disease.
        J Endocrinol Invest. 2000; 23: 321-324
        • Korem M.
        • Miller A.
        Vitamin B12 levels and auto-antibody formation associated with interferon-β and Copaxone therapy in multiple sclerosis patients.
        in: Proceedings of the ECTRIM2001
        • Scalabrino G.
        • Buccellato F.R.
        • Veber D.
        • Mutti E.
        New basis of the neurotrophic action of vitamin B12.
        Clin Chem Lab Med. 2003; 41: 1435-1437
        • Mastronardi F.G.
        • Min W.
        • Wang H.
        • Winer S.
        • Dosch M.
        • Boggs J.M.
        • et al.
        Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance.
        J Immunol. 2004; 172: 6418-6426